The development of monoclonal antibodies for early diagnosis and therapeutic application in Alzheimer’s disease

Alzheimer’s disease is the most common neurodegenerative disorder. The recent immunotherapy brings the hope of treating AD as suggested by several preclinical studies. This project first aims to develop a humanized monoclonal antibody to target the molecules involved in generating a toxic protein of AD, named amyloid ?, and test the application of this antibody […]

Read More